Exosome treatments are increasingly offered by aesthetic clinics, usually in combination with procedures such as microneedling, radiofrequency microneedling or fractional laser. They are promoted for skin rejuvenation, improved recovery after procedures, pigmentation, acne scars and hair restoration.
This guide concerns professional treatments performed or applied in clinics. It does not cover over-the-counter exosome serums or products intended for home use.
The biology behind extracellular vesicles is scientifically important, but aesthetic use has developed faster than the clinical evidence. Different products marketed as “exosomes” can also differ substantially in biological source, composition, manufacturing and characterisation. Results obtained with one specific preparation cannot automatically be applied to every product marketed as an exosome treatment.
For a deeper analysis of the science and current evidence, read Exosomes in Aesthetic Medicine: Fascinating Biology, Missing Evidence.
For a closer look at individual commercial formulations, read Exosomes in Aesthetic Medicine — Part II: Product Teardown.
What are exosomes?
Exosomes are a subtype of extracellular vesicle released by cells. They can carry proteins, lipids, RNA and other signalling molecules involved in communication between cells.
Because these signalling pathways may influence inflammation, wound healing, collagen production, pigmentation and hair cycling, extracellular vesicles are being investigated across regenerative medicine and dermatology. Much of the mechanistic evidence, however, still comes from laboratory and preclinical research rather than large human clinical trials.
The term “exosome” is also used loosely in the aesthetics market. Some products contain extracellular vesicles, while others may contain conditioned media, secretome components, growth factors or additional active ingredients.
The biological source matters. Products described as exosome-based may originate from mesenchymal stem cells, adipose tissue, placenta, platelets or other sources. Plant-derived extracellular vesicles are also being investigated, but they are biologically different from human cell-derived exosomes.
How are exosome treatments used in aesthetic clinics?
The most common aesthetic approach is to apply an exosome or extracellular-vesicle preparation immediately after a procedure that temporarily disrupts the skin barrier.
Common combinations include:
- Microneedling
- Radiofrequency microneedling
- Fractional CO2 laser
- Other fractional laser treatments
- Laser resurfacing
This approach is used because intact skin is a significant barrier to the penetration of complex biological particles. Microneedling and laser create temporary channels or controlled tissue injury, allowing a topical preparation greater contact with the treated tissue. Clinical studies of exosome-based skin rejuvenation therefore frequently evaluate exosomes as an adjunct to another procedure rather than as a stand-alone treatment.
Some clinics also use exosome-based treatments for the scalp, often together with microneedling or RF microneedling.
Injected exosome treatments should be considered separately from topical application. Injection introduces the product directly into tissue and carries different safety and regulatory considerations. Published case reports and case series have described serious and persistent skin reactions following intradermal injection of unapproved exosome-based formulations.
What can exosome treatments potentially help with?
Skin rejuvenation
Early clinical research suggests that exosome or extracellular-vesicle treatments may improve some measures of skin hydration, elasticity, texture, pigmentation and wrinkles.
However, studies use different products, concentrations, biological sources and delivery methods. Sample sizes are often small, follow-up is relatively short, and some studies lack appropriate control groups.
Recent reviews therefore describe the results as promising while emphasising the need for larger, well-controlled and independently replicated studies.
Microneedling with exosomes
Microneedling combined with exosome-based preparations is one of the better-studied aesthetic combinations.
A prospective split-face study found improvements in facial skin-aging parameters when a stem-cell-conditioned media preparation was combined with microneedling. More recent reviews have also found encouraging results, while noting that current evidence is not yet sufficient to establish an optimal protocol or long-term safety profile.
It is important to remember that microneedling itself stimulates a wound-healing response and collagen remodelling. When a study combines microneedling with an exosome preparation, it can be difficult to determine how much of the final result is attributable specifically to the added product.
Laser treatments with exosomes
Exosome preparations have also been studied after fractional laser treatments.
A split-face study evaluating adipose-derived stem-cell exosomes after fractional CO2 laser found greater improvement in acne scars and several skin parameters on the exosome-treated side compared with laser alone.
This provides interesting evidence for that specific preparation and protocol, but it does not demonstrate that every commercial exosome product will produce the same result.
Acne scars
The combination of fractional laser and extracellular-vesicle preparations has shown promising early results for atrophic acne scars.
Exosomes are being investigated as an adjunct intended to influence wound healing and tissue remodelling after the laser creates controlled skin injury.
Evidence remains limited compared with established acne-scar treatments, and results from one exosome preparation should not be extrapolated to unrelated products.
Pigmentation and uneven skin tone
Extracellular-vesicle treatments are being investigated for pigmentation disorders, post-inflammatory hyperpigmentation and photoaging.
Small studies have reported changes in pigmentation and redness after combination treatments. One study of rose-derived extracellular vesicles combined with microneedling included only a small number of participants, illustrating why early positive results need further confirmation.
Hair thinning and hair loss
Exosome-based treatments are increasingly investigated for androgenetic alopecia and other forms of hair thinning.
A 2025 review identified nine clinical studies involving 125 patients treated with exosome-based approaches for hair loss. Other prospective research has evaluated exosome therapy combined with microneedling, while RF microneedling followed by topical exosome application has also entered clinical research.
The results are encouraging, but protocols vary considerably and the evidence base remains much smaller than for established medical treatments for androgenetic alopecia. A correct diagnosis of the cause of hair loss remains important before choosing treatment.
How strong is the evidence?
The evidence is promising but still developing.
Major limitations include:
- Small patient populations
- Different biological sources
- Different isolation and manufacturing processes
- Inconsistent characterisation of what a product actually contains
- Different concentrations and dosing protocols
- Frequent combination with microneedling or laser
- Short follow-up periods
- Limited independent replication
- Potential conflicts of interest in parts of the literature
A 2026 scoping review concluded that exosome-based dermatological therapies show promise but highlighted small samples, short follow-up, non-randomised designs and potential conflicts of interest as important limitations.
Exosome treatments should therefore currently be considered an emerging area of aesthetic medicine rather than a single, standardised treatment with a well-established evidence base.
Which exosome products are used in clinics?
There is no single standard exosome product.
RealSelf has reported professional aesthetic use in the United States of brands including Benev, Exocel Bio and Rion. Published clinical research has evaluated other named preparations, including ASCE+ and Exodew.
These products should not be considered interchangeable.
They can differ in:
- Biological source
- Isolation and purification method
- Exosome or extracellular-vesicle concentration
- Additional growth factors or active ingredients
- Storage requirements
- Intended delivery method
- Available clinical evidence
Product availability also differs between countries. A product being offered by clinics does not mean that it has been approved as an exosome therapy, and published results involving one formulation do not validate every other product marketed using the same terminology.
For this reason, patients should ask the clinic directly which exact product is used.
What happens during an exosome treatment?
The procedure depends on the treatment being combined with the product.
A typical skin treatment may involve:
- Cleansing and preparing the skin.
- Applying topical anaesthetic if required.
- Performing microneedling, RF microneedling or laser treatment.
- Applying the exosome or extracellular-vesicle preparation to the treated area.
- Following specific post-treatment skincare instructions.
There is currently no universally accepted protocol for concentration, treatment interval or number of sessions.
How many sessions are needed?
There is no standard treatment schedule.
Protocols used in published research vary, while clinics may recommend a single session or a series of treatments depending on the indication and the accompanying procedure.
Because different products and treatment combinations cannot automatically be considered equivalent, the protocol should be discussed with the treating clinic.
When will results appear?
There is no universal timeline.
Temporary improvements in hydration or skin appearance may occur relatively quickly, particularly when a formulation contains additional moisturising or soothing ingredients.
Changes involving collagen remodelling, texture or pigmentation generally require more time and may develop over several weeks.
Long-term durability is still uncertain because many clinical studies have relatively short follow-up periods, although individual studies have reported longer-lasting improvements with specific protocols.
Downtime and recovery
Downtime usually depends more on the accompanying procedure than on the exosome product.
After microneedling or laser, temporary effects may include:
- Redness
- Mild swelling
- Sensitivity
- Dryness
- Pinpoint bleeding after microneedling
- Peeling or crusting after more intensive laser resurfacing
One reason exosome preparations are increasingly used after aesthetic procedures is the possibility that they may influence inflammation and wound healing. Some early studies suggest improved recovery, but the size and consistency of this effect have not yet been established in large independent trials.
Risks and side effects
The risk profile depends strongly on the product and how it is administered.
With topical application after microneedling or laser, possible problems include:
- Irritation
- Redness and swelling
- Allergic or inflammatory reactions
- Infection
- Post-inflammatory hyperpigmentation
- Reactions to other ingredients in the formulation
The quality, sterility, purification, storage and characterisation of biologically derived products are particularly important.
Injection creates additional concerns. Serious persistent inflammatory reactions and other cutaneous complications have been reported after intradermal administration of unapproved exosome formulations.
Are exosome treatments FDA or EMA approved?
Regulatory status depends on the type of product and its intended use.
Recent academic regulatory reviews report that no extracellular-vesicle therapeutic has yet received FDA approval and that no mesenchymal-stem-cell-derived secretome or exosome product has received FDA or EMA approval for dermatological use.
This does not mean that every topical cosmetic product used after an aesthetic procedure is automatically prohibited. Cosmetic products and biological therapies can fall under different regulatory frameworks.
However, availability in an aesthetic clinic should not be confused with regulatory approval as an exosome therapy.
Patients considering treatment should ask the clinic about the exact product, its intended use and the applicable regulatory status.
Who may consider an exosome treatment?
Exosome-based treatment may be worth discussing with a qualified practitioner if:
- You are already considering microneedling or laser and want to discuss an adjunctive treatment.
- Your goal is gradual improvement in skin quality.
- You understand that the evidence is still emerging.
- You understand that the additional benefit over the underlying procedure may be uncertain.
- You are comfortable asking the clinic detailed questions about the product being used.
Suitability also depends on the accompanying procedure and your medical history.
People with active skin infections, significant inflammatory skin disease, impaired wound healing or other relevant medical conditions should discuss these issues with the treating practitioner.
Exosomes compared with PRP
Exosomes and platelet-rich plasma are not the same treatment.
PRP is prepared from the patient's own blood, while commercial exosome or extracellular-vesicle preparations come from an external biological source.
A 2025 split-face study comparing adipose-derived mesenchymal stem-cell exosomes with PRP reported improvement with both approaches and did not find significant differences between the treatment arms for several measured outcomes.
This is not enough evidence to conclude that exosomes are generally better than PRP.
How to choose a clinic
Do not ask only, “Do you offer exosomes?”
Useful questions include:
- What is the exact product name?
- What is its biological source?
- What does the preparation actually contain?
- Is it applied topically or injected?
- Why is this delivery method being recommended?
- What evidence exists for this exact product?
- Is the evidence based on human clinical studies?
- What other ingredients are included?
- How is the product stored and prepared?
- What results are expected from the exosome component itself?
- What results are expected from the microneedling or laser treatment?
- Are there better-established alternatives for my concern?
The clinic should be able to explain clearly what it is using and why.
How much do exosome treatments cost?
There is no standard price because “exosome treatment” can describe very different procedures.
The total price may include:
- The exosome or extracellular-vesicle preparation
- Microneedling
- RF microneedling
- Laser treatment
- Scalp treatment
- Multiple treatment sessions
Some clinics charge for the exosome preparation as an add-on, while others include it within a complete treatment protocol.
Compare the complete treatment being offered rather than comparing prices based only on the word “exosomes.”